Since 2019 why has this stock soared as much as 9000+% ?
Livestreaming and digital currencies will never be the same. That's because this disruptor's come along.

The only public company with direct exposure to a coin up 5500+% YTD. And it’s a livestreaming platform.
Who is it? You may be shocked.

SPRB Insider Trading (Spruce Biosciences)

Insider Ownership Percentage: 9.10%
Insider Buying (Last 12 Months): $6,750,000.00
Insider Selling (Last 12 Months): $6,834,293.16

Spruce Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Spruce Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Spruce Biosciences Share Price & Price History

Current Price: $6.30
Price Change: Price Decrease of -0.09 (-1.41%)
As of 09/24/2021 12:48 PM ET

This chart shows the closing price history over time for SPRB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A mental health disruptor.
A $2BB+ antidepressant market doesn't work for 264M humans.
This may change.

Spruce Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2021Camilla V SimpsonDirectorSell334$15.29$5,106.86334View SEC Filing Icon  
5/19/2021Holdings A/S NovoMajor ShareholderSell475,000$13.90$6,602,500.004,514,336View SEC Filing Icon  
4/30/2021Camilla V SimpsonDirectorSell14,045$16.14$226,686.3014,045View SEC Filing Icon  
10/14/2020Bali MuralidharDirectorBuy200,000$15.00$3,000,000.00View SEC Filing Icon  
10/14/2020Venture Fund Iii L RivervestMajor ShareholderBuy250,000$15.00$3,750,000.004,739,336View SEC Filing Icon  
See Full Table
Insider Selling at Spruce Biosciences?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Spruce Biosciences and related companies.

SEC Filings (Institutional Ownership Changes) for Spruce Biosciences (NASDAQ:SPRB)

85.99% of Spruce Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SPRB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Spruce Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2021Morgan Stanley122,590$1.38M0.0%+257.5%0.524%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN7,034$79K0.0%+223.6%0.030%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC17,216$0.19M0.0%-76.4%0.074%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP92,412$1.04M0.0%N/A0.395%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE7,853$88K0.0%-39.0%0.034%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System12,006$0.14M0.0%+14.0%0.051%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.19,413$0.22M0.0%N/A0.083%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley122,590$1.38M0.0%+257.5%0.524%Search for SEC Filing on Google Icon
8/16/2021State Street Corp124,918$1.40M0.0%+31.8%0.534%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC29,616$0.33M0.0%+159.3%0.127%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.10,770$0.12M0.0%-13.5%0.046%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp77,864$0.87M0.0%+2.3%0.334%Search for SEC Filing on Google Icon
8/13/2021Laurion Capital Management LP14,957$0.17M0.0%-25.2%0.064%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC128,546$1.44M0.0%+17.3%0.551%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.369,520$4.14M0.0%+96.0%1.584%Search for SEC Filing on Google Icon
8/13/2021FMR LLC1,185,673$13.29M0.0%-0.8%5.082%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.163,857$1.84M0.0%-9.0%0.702%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp25,566$0.29M0.0%+33.3%0.110%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.419,789$4.71M0.0%+21.6%1.799%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC73,081$1.21M0.0%-41.4%0.313%Search for SEC Filing on Google Icon
5/18/2021PFM Health Sciences LP489,631$8.13M0.2%-7.5%2.099%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley34,292$0.57M0.0%+543.5%0.147%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC1,702,805$28.27M0.0%+0.1%7.299%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP1,579,301$26.22M0.6%-3.2%6.769%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC11,422$0.19M0.0%-49.6%0.049%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.12,447$0.21M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG23,899$0.40M0.0%-7.1%0.103%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp19,180$0.32M0.0%+42.2%0.082%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp76,144$1.26M0.0%-3.9%0.327%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC109,547$1.82M0.0%-6.8%0.470%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.180,023$2.99M0.0%-4.7%0.773%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund6,000$100K0.0%+87.5%0.026%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.345,306$5.73M0.0%+4.0%1.482%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio2,400$39K0.0%+41.2%0.010%Search for SEC Filing on Google Icon
2/19/2021PFM Health Sciences LP529,311$12.87M0.5%N/A2.280%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.188,827$4.59M0.0%N/A0.813%Search for SEC Filing on Google Icon
2/17/2021Sands Capital Management LLC787,007$19.13M0.0%N/A3.390%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC22,666$0.55M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.40,352$0.98M0.0%N/A0.174%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.4,050$98K0.0%N/A0.017%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP10,000$0.24M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/12/2021Laurion Capital Management LP20,000$0.49M0.0%N/A0.086%Search for SEC Filing on Google Icon
2/12/2021AWM Investment Company Inc.40,000$0.97M0.1%N/A0.172%Search for SEC Filing on Google Icon
2/12/2021Credit Suisse AG25,713$0.63M0.0%N/A0.111%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp79,204$1.93M0.0%N/A0.341%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.1,282$31K0.0%N/A0.006%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN3,724$90K0.0%N/A0.016%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp13,492$0.33M0.0%N/A0.058%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund3,200$78K0.0%N/A0.014%Search for SEC Filing on Google Icon
2/6/2021Granite Point Capital Management L.P.100,000$2.43M0.1%N/A0.431%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.332,032$8.07M0.0%N/A1.430%Search for SEC Filing on Google Icon
2/4/2021Aisling Capital Management LP1,205,511$29.31M5.0%N/A5.193%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Spruce Biosciences logo
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH). It offers tildacerfont, which is in Phase II clinical trial for children with classic CAH; and for females with polycystic ovary syndrome. In addition, it is involved in developing CAHmelia-203 which is in Phase 2b clinical trial for adult patients with classic CAH with poor disease control; and CAHmelia-204, which is in second Phase 2b clinical trial in adult patients with classic CAH with good disease control. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California.
Read More on Spruce Biosciences

Today's Range

Now: $6.30
Low: $6.30
High: $6.30

50 Day Range

MA: $8.15
Low: $6.36
High: $10.00

52 Week Range

Now: $6.30
Low: $6.16
High: $35.60

Volume

15 shs

Average Volume

57,696 shs

Market Capitalization

$147.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Spruce Biosciences?

Spruce Biosciences' top insider investors include:
  1. Venture Fund Iii L Rivervest (Major Shareholder)
  2. Holdings A/S Novo (Major Shareholder)
  3. Camilla V Simpson (Director)
  4. Bali Muralidhar (Director)

Who are the major institutional investors of Spruce Biosciences?

Spruce Biosciences' top institutional shareholders include:
  1. FMR LLC — 5.08%
  2. BlackRock Inc. — 1.80%
  3. Vanguard Group Inc. — 1.58%
  4. JPMorgan Chase & Co. — 0.70%
  5. Geode Capital Management LLC — 0.55%
  6. State Street Corp — 0.53%

Which institutional investors are selling Spruce Biosciences stock?

During the last quarter, SPRB stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. JPMorgan Chase & Co.
  3. FMR LLC
  4. Laurion Capital Management LP
  5. Bank of America Corp DE
  6. Goldman Sachs Group Inc.
During the previous year, company insiders that have sold Spruce Biosciences company stock include:
  1. Venture Fund Iii L Rivervest (Major Shareholder)
  2. Holdings A/S Novo (Major Shareholder)

Which institutional investors are buying Spruce Biosciences stock?

Within the last quarter, SPRB stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. Caas Capital Management LP
  3. Morgan Stanley
  4. Morgan Stanley
  5. BlackRock Inc.
  6. State Street Corp
  7. Alyeska Investment Group L.P.
  8. Geode Capital Management LLC
In the previous year, these company insiders have bought Spruce Biosciences stock:
  1. Venture Fund Iii L Rivervest (Major Shareholder)
  2. Holdings A/S Novo (Major Shareholder)
Inflation's top hedge.
These robust gold reserves for tailor-made for 2021.
See why for yourself.